Energy balance-related factors and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1335
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Energy balance-related factors and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status ; day:11 ; month:5 ; year:2022 ; pages:1-20
Journal of cancer research and clinical oncology ; (11.5.2022), 1-20
- Urheber
-
Jenniskens, Josien C. A.
Offermans, Kelly
Simons, Colinda C. J. M.
Samarska, Iryna
Fazzi, Gregorio E.
Meer, Jaleesa R. M. van der
Smits, Kim M.
Schouten, Leo J.
Weijenberg, Matty P.
Grabsch, Heike I.
Brandt, Piet A. van den
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00432-022-04019-9
- URN
-
urn:nbn:de:101:1-2022071709233523739011
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jenniskens, Josien C. A.
- Offermans, Kelly
- Simons, Colinda C. J. M.
- Samarska, Iryna
- Fazzi, Gregorio E.
- Meer, Jaleesa R. M. van der
- Smits, Kim M.
- Schouten, Leo J.
- Weijenberg, Matty P.
- Grabsch, Heike I.
- Brandt, Piet A. van den
- SpringerLink (Online service)
Ähnliche Objekte (12)
Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancer
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis?
Prävalenz und Heterogenität von KRAS-, BRAF- und PIK3CA-Mutationen in Magenkarzinomen und ihren Metastasen
Mutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA
Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma
Prävalenz und Heterogenität von KRAS, BRAF und PIK3CA Mutationen in kolorektalen Adenokarzinomen und ihren korrespondierenden Metastasen
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer
Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia
KRAS and BRAF mutational status in colon cancer from Albanian patients
The Prevalence of BRAF, PIK3CA, and RAS Mutations in Indian Patients with Colorectal Cancer
Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancer
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis?
Prävalenz und Heterogenität von KRAS-, BRAF- und PIK3CA-Mutationen in Magenkarzinomen und ihren Metastasen
Mutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA
Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma
Prävalenz und Heterogenität von KRAS, BRAF und PIK3CA Mutationen in kolorektalen Adenokarzinomen und ihren korrespondierenden Metastasen
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer
Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia
KRAS and BRAF mutational status in colon cancer from Albanian patients
The Prevalence of BRAF, PIK3CA, and RAS Mutations in Indian Patients with Colorectal Cancer
Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancer
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis?
Prävalenz und Heterogenität von KRAS-, BRAF- und PIK3CA-Mutationen in Magenkarzinomen und ihren Metastasen
Mutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA
Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma
Prävalenz und Heterogenität von KRAS, BRAF und PIK3CA Mutationen in kolorektalen Adenokarzinomen und ihren korrespondierenden Metastasen
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer
Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia
KRAS and BRAF mutational status in colon cancer from Albanian patients